WhatsApp
Click Here
Click Here
 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: June 2023
Volume 8 | Issue 6
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 8
Issue Published : 85
Article Submitted : 7821
Article Published : 4002
Total Authors : 10443
Total Reviewer : 547
Total Countries : 81
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | PREPARATION AND CHARACTERIZATION OF NABUMETONE ETHOSOMAL GEL |
| Authors Name: | Hazira Bin Ahmed |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_181338
|
| Published Paper Id: | IJRTI2008019 |
| Published In: | Volume 5 Issue 8, August-2020 |
| DOI: | |
| Abstract: | Background: The present study aimed to develop an Ethosomal formulation for topical delivery of Nabumetone to enhance the water solubility as well as the permeability of the drug.The ethosomes was prepared by cold method, ethanol is used as a penetration enhancer.F1 to F12 different formulation of ethosomes are prepared and characterized for size and shape analysis, entrapment efficacy. Carbopol 934 is used as a gelling agent. The prepared formulation was evaluated for spreadability, in vitro diffusion study, in vivo skin permeation study. Nabumetone is NSAID belongs bio pharmaceutics classification system (BCS) class II drug, widely used in the treatment of osteoarthritis and rheumatoid arthritis. The most frequently reported adverse reactions for the drug involve a disturbance in the gastrointestinal tract, diarrhea, dyspepsia, and abdominal pain. |
| Keywords: | Nabumetone, Ethosomes, topical delivery, Phospholipid, Anti-inflammatory activity. |
| Cite Article: | "PREPARATION AND CHARACTERIZATION OF NABUMETONE ETHOSOMAL GEL", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.5, Issue 8, page no.103 - 106, August-2020, Available :http://www.ijrti.org/papers/IJRTI2008019.pdf |
| Downloads: | 000202437 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2008019
Registration ID:181338
Published In: Volume 5 Issue 8, August-2020
DOI (Digital Object Identifier):
Page No: 103 - 106 Country: HYDERABAD, TELANGANA, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2008019 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2008019 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Join RMS/Earn 300
Indexing Partner |
|||
| Copyright © 2023 - All Rights Reserved - IJRTI | |||
Facebook Twitter Instagram LinkedIn